Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Franklin Hendrick, BS
Articles
Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related Therapies
Amy J. Davidoff, PhD;Amer Zeidan, MD;Franklin Hendrick, BS;Bruce C. Stuart, PhD;Vu H. Duong, MD, MS;Maria R. Baer, MD;Rahul A. Shenolikar, PhD;Steven D. Gore, MD
March 17th 2015Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
Read More
Latest Updated Articles
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
